Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...

Leading artificial intelligence (AI) driven drug discovery and bioinformatics, Dr. Sita Sirisha Madugula is making ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Sapio Sciences has integrated the NVIDIA BioNeMo platform into its lab informatics platform, enhancing AI-driven ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

A multicenter study led by Cedars-Sinai created a database of adverse medication events—the fourth leading cause of death in ...

We recently published a list of Top 9 AI Ratings and News Updates on Wall Street’s Radar. In this article, we are going to ...

While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...

This eBook explores the latest advancements in drug discovery, from AI-driven precision medicine to the promise and risks of ...